Rokid, a pioneer in human-computer interaction and Augmented Reality, announced today that its newly launched Rokid Glasses have surpassed $1 million in crowdfunding pledges on Kickstarter within just four days. The milestone highlights strong international demand for the world's lightest full-function AI & AR smart glasses. https://mma.prnewswire.com/media/2761959/image_5028920_49227651.jpg The announcement follows a Bloomberg TV live segment […]

In the news release, FORCYD announces its expansion into France with the opening of a new office in Paris, issued 01-Sep-2025 by FORCYD over PR Newswire, we are advised by the company that the Dateline City should read 'PARIS' rather than 'AMSTERDAM' as originally issued inadvertently. The complete, corrected release follows: FORCYD announces its expansion

NEW YORK, NY / ACCESS Newswire / September 1, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=164647&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the “Class Period”), of the importantOctober 6, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg So What: If you purchased Altimmunesecurities you may be entitled to compensation without

NEW YORK, NY / ACCESS Newswire / September 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeMD, Inc. ("LifeMD, Inc.") (NASDAQ:LFMD) concerning possible violations of federal securities laws. LifeMD announced its second quarter 2025 results on August 5, 2025. Among other items, the Company revealed that higher customer

NEW YORK, NY / ACCESS Newswire / September 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of AVITA Medical, Inc. ("AVITA Medical, Inc.") (NASDAQ:RCEL) concerning possible violations of federal securities laws. AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a "significant

28th August, The 2025 19th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 4th New Investment Event, hosted by Frost & Sullivan and co-organized by LeadLeo, was successfully held at the Jing'an Shangri-La Hotel in Shanghai from August 27 to 28, 2025. With the theme of "Intelligence Initiates a New Journey'Jointly Shaping

NEW YORK, NY / ACCESS Newswire / September 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lantheus Holdings, Inc. ("Lantheus Holdings, Inc.") (NASDAQ:LNTH) concerning possible violations of federal securities laws. On August 6, 2025, Lantheus reported its financial results for the second quarter of 2025 which missed analyst

NEW YORK, NY / ACCESS Newswire / September 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Six Flags Entertainment Corporation ("Six Flags Entertainment Corporation") (NYSE:FUN) concerning possible violations of federal securities laws. On August 6, 2025, Six Flags issued a press release announcing disappointing second quarter fiscal 2025

Nord Anglia schools outperform England's average at both grades 9-7 (A*-A) and 9-4 (A*-C). Students across Nord Anglia Education's global family of schools have once again achieved exceptional academic results in their I/GCSE examinations, with performance rising year on year and continuing to exceed national averages in England. https://mma.prnewswire.com/media/1503193/Nord_Anglia_Education_Logo.jpg This year, 48.1% of all Nord